A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents
Clinical trial NCT00210483 · COMPLETED
Trial details
- NCT number
- NCT00210483
- Sponsor
- Janssen-Ortho LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Enrollment
- 866
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.